Avoid panic, wear that mask: Coronavirus being airborne means covering face for longer time
Meeting at crowded and closed places should be avoided strictly.
Scientists identify drugs that may block coronavirus from jumping to uninfected cells
They said sometimes this hijacking interferes with the ...
CCMB develops new, low-cost testing method for covid-19; ICMR nod awaited
It eliminates the time-consuming RNA extraction in testing and impo...
Proteins in COVID-19 patients' blood could predict severity of illness, study finds
In research published in the journal Cell Systems on Tuesday, scientists at Britain's Francis Crick Institute and Germany's Charite Universitaetsmedizin Berlin found the proteins are present in different levels in COVID-19 patients, depending on the severity of their symptoms.
Mylab launches machine to automate molecular diagnostic tests including those for COVID-19
Earlier in March, Mylab had received commercial approval from the Central Drugs Standard Control Organisation (CDSCO) for its COVID-19 test kit, which it said was the first 'Made in India' kit to receive such an approval from the regulator.
Coronavirus: SC refuses to hear plea for directing Centre to move ICJ for compensation from China
A bench comprising Chief Justice S A Bobde and Justices Dinesh Maheshwari and A S Bopanna said it would not entertain PIL which claimed there was strong evidence that coronavirus or COVID-19, which has "destroyed" the Indian economy and killed hundreds of it citizens, originated from China's Wuhan Institute of Virology.
Six Indian companies working on COVID-19 vaccine, many challenges in finding a preventive: Experts
Nearly 70 'vaccine candidates' are being tested and at least three have moved to the human clinical trial stage, but a vaccine for the novel coronavirus is unlikely to be ready for mass use before 2021.
Biosimilar drugs can help us reach $1 billion target soon: Christiane Hamacher, CEO, Biocon Biologics
It is all about reaching our $1billion revenue target by FY22 and to reach 5 million patients by end of 2022, says Christiane Hamacher.
US scientists link BCG vaccination with fewer coronavirus cases, Indian scientists hopeful but cautious
"We found that countries without universal policies of BCG vaccination, such as Italy, the Netherlands, and the United States, have been more severely affected compared to countries with universal and long-standing BCG policies," noted the researchers led by Gonzalo Otazu, assistant professor of biomedical sciences at NYIT.
From 4,000 tests on April 1, India hits 2 lakh daily COVID testing target
Top Central government officials monitoring the COVID 19 testing scenario in the country then said that the testing apparatus was being ramped up in a strategic fashion, to stay ‘ahead of the virus’ and deploy resources judiciously as the virus spread into the country starting first from urban centres.
Scientists strike note of caution as 'Made in India' vaccine programme gains momentum
India's premier medical body ICMR has said 12 clinical trial sites for the indigenous Covaxin, being developed in collaboration with the Hyderabad-based Bharat Biotech and the National Institute of Virology (NIV), have been identified.
NCBS scientists identify 33 molecules that could be used to treat virus patients
A group of scientists led by Professor R. Sowdhamini at NCBS has identified the 33 small molecules from a database of over 3,30,000 small molecules using new computational research, which bind to NSP1, one of the SARS-CoV-2 proteins. The scientists have recommended that these can be taken forward for wet-lab validation.
Mutations, unusual symptoms, and other COVID-19 mysteries that remain unsolved
Many patient samples had also yielded false positive in dengue diagnosis tests.
How a Chinese firm jumped to the front of the virus vaccine race
In May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows researchers worldwide to assess a vaccine’s potential. The company is yet to generate revenue and logged a $22 million loss last year.
Up to 45 per cent of coronavirus infections may be asymptomatic: Study
The findings, published in the journal Annals of Internal Medicine, suggested that asymptomatic people may account for approximately 40 to 45 per cent of SARS-CoV-2 infections, playing a significant role in the spread of the disease.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service